FindTrial
Sign In

Efficacy and safety of deliberate hypotension on reducing perioperative blood loss in primary total hip arthroplasty

Efficacy and safety of deliberate hypotension on reducing perioperative blood loss in primary total hip arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041030
Enrollment
Unknown
Registered
2020-12-16
Start date
2020-12-20
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage hip disease

Interventions

Deliberate hypotension group:Nil
Non-deliberate hypotension group:Nil

Sponsors

West China Hospital, Sichuan Univercity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age>=18 years, regardless of gender; 2.Patients underwent primary total hip arthroplasty for the treatment of end-stage hip diseases; 3.American Society of Anesthesiologists (ASA) grade was I-III grade.

Exclusion criteria

Exclusion criteria: 1.Revision surgery; 2.Patients with cerebrovascular accident and neuropathy; 3.Patients with cardiopulmonary disease and hepatorenal disfunction; 4.Patients with severe anemia, hypovolemia, and coagulation disorders; 5.Patients with refactory hypertension and peripheral vascular diseases.

Design outcomes

Primary

MeasureTime frame
Perioperative blood loss;Intraoperative blood loss;Hidden blood loss;—

Secondary

MeasureTime frame
Blood transfusion rate/volume;Operation time;Post-operative cardio-cerebrovascular complication;Post-operative hepatorenal dysfunction;Mortality;Coagulation markers;—

Countries

China

Contacts

Public ContactZeng Yi
zengyigd@126.com+86 189-8060-2289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026